Featured Research

from universities, journals, and other organizations

Novel molecular pathway regulates invasive growth and metastasis in estrogen receptor-positive breast cancer

Date:
July 5, 2010
Source:
Ghent University
Summary:
Researchers have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.

A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France has uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.

Related Articles


Cancers achieve invasive growth by delivering pro-invasive molecules into the tumor micro-environment, but the molecular mechanisms for the secretion of these proinvasive growth regulators remain largely unknown. One likely process involves release of vesicle content (exocytosis). Key players in exocytosis include the small Rab GTPases, which serve as molecular modulators of cellular vesicle membrane trafficking. Rab27B belongs to the family of secetory Rab GTPases, and controls the secretory process of vesicles.

The investigators demonstrated that over-expression of Rab27B in non-invasive breast cancer cell lines promoted cell cycle progression, proliferation and invasiveness of breast cancer cells in vitro. Mass spectrometry identified HSP90-alpha, a chaperone molecule, as a key pro-invasive growth regulator that was secreted in a Rab27B-dependent fashion into the micro-environment and was required for the activation of matrix metallo proteinase-2, a key player in breakdown of the extracellular matrix. In an in vivo xenograft mouse model, the investigators showed that invasive tumor growth and hemorrhagic ascites was induced by Rab27B.

To translate their research results from bench to bedside, the investigators studied the expression levels of Rab27B in primary breast cancer samples. Statistical analysis revealed that up-regulation of Rab27B was associated with lymph node metastasis and tumor differentiation grade in estrogen receptor-positive human breast tumors.

In conclusion, derailed Rab27B-mediated exocytosis regulates invasive growth and metastasis in ER-positive breast cancer cell lines, and increased expres­sion is associated with poor prognosis in humans. Considerable thera­peutic potential may reside in efforts to control Rab27B levels and to modulate Rab27B-regulated pathways through pharmacological or genetic interventions.


Story Source:

The above story is based on materials provided by Ghent University. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Hendrix, D. Maynard, P. Pauwels, G. Braems, H. Denys, R. Van den Broecke, J. Lambert, S. Van Belle, V. Cocquyt, C. Gespach, M. Bracke, M. C. Seabra, W. A. Gahl, O. De Wever, W. Westbroek. Effect of the Secretory Small GTPase Rab27B on Breast Cancer Growth, Invasion, and Metastasis. JNCI Journal of the National Cancer Institute, 2010; 102 (12): 866 DOI: 10.1093/jnci/djq153

Cite This Page:

Ghent University. "Novel molecular pathway regulates invasive growth and metastasis in estrogen receptor-positive breast cancer." ScienceDaily. ScienceDaily, 5 July 2010. <www.sciencedaily.com/releases/2010/07/100705125251.htm>.
Ghent University. (2010, July 5). Novel molecular pathway regulates invasive growth and metastasis in estrogen receptor-positive breast cancer. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2010/07/100705125251.htm
Ghent University. "Novel molecular pathway regulates invasive growth and metastasis in estrogen receptor-positive breast cancer." ScienceDaily. www.sciencedaily.com/releases/2010/07/100705125251.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) — NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) — A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) — Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com
British Navy Ship Arrives in Sierra Leone With Ebola Aid

British Navy Ship Arrives in Sierra Leone With Ebola Aid

AFP (Oct. 30, 2014) — The British ship RFA ARGUS arrived in Sierra Leone to deliver supplies and equipment to help the fight against Ebola. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins